Remimazolam as a Primary Agent for Brief Invasive and Noninvasive Procedures: A Case Series

Remimazolam is a novel benzodiazepine with sedative and amnestic properties similar to midazolam. Ester metabolism results in a half-life of 5 - 10 min and a limited context sensitive half-life. We present preliminary retrospective experience with its use as a primary agent for procedural sedation f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Jessica, McKee, Christopher, Chenault, Kristin, Tobias, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079368/
https://www.ncbi.nlm.nih.gov/pubmed/37035849
http://dx.doi.org/10.14740/jocmr4870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079368/
https://www.ncbi.nlm.nih.gov/pubmed/37035849
http://dx.doi.org/10.14740/jocmr4870

Ejemplares similares